News
The Food and Drug Administration approved Papzimeos (zopapogene imadenovec-drba) for the treatment of adults with recurrent ...
The U.S. Food and Drug Administration has started "real-time reporting of adverse event data," according to an annoucement ...
Outlook Therapeutics nears FDA decision on Lytenava, with EU sales, exclusivity, and high upside potential despite current ...
System integrates glucose biosensor with an AI-driven platform to show how food, activity, stress, sleep affect the body in ...
A. The Food and Drug Administration has approved montelukast to treat asthma, exercise-induced bronchoconstriction (trouble ...
The FDA classifies this recall as Class II, which the agency describes as a situation "in which use of or exposure to a ...
Shaman Botanicals has issued a formal response to the FDA’s recent warning letter on its 7-hydroxymitragynine (7-OH) products ...
FDA recalls 7Up Zero Sugar Tropical Soda for being mislabeled full-sugar soda. The affected cans were sold in 12-packs in ...
After a more than decadelong process to bring the experimental drug elamipretide to market, the treatment’s approval has ...
By Sneha S K and Bageshri Banerjee (Reuters) -The U.S. Food and Drug Administration on Thursday approved Ionis ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results